In plain English
Eli Lilly and Co. develops and sells prescription medicines, focusing on diabetes, obesity and oncology treatments. The company is a…
Company stock · NYSE · USD
Eli Lilly and Co
$1,273.46
Today
−$33.23-2.54%
vs yesterday’s close
Live price
Themes
Price chart Pro
Company briefing
Plain English context — why the name shows up in the news, and what to watch next.
Eli Lilly and Co. develops and sells prescription medicines, focusing on diabetes, obesity and oncology treatments. The company is a…
Latest on this name
12 recent cards — open any for the full deeper dive.
The move comes after the company’s latest earnings beat expectations and its guidance for the next quarter remains strong.
Schumer’s 50th‑anniversary critique of the Hyde Amendment spotlights the financial barriers it imposes on low‑income Americans seeking abortion care.
HIV funding cuts risk undoing decades of progress; ensuring medicines reach patients is as vital as keeping costs low.
AI can uncover life‑saving drug combos quickly, boosting both pharma innovation and AI investment.
Ken Langone projects Eli Lilly could reach $2,000 per share in 3–4 years, a 70.92% upside from today’s price, driven by a strong pipeline and Medicare gains.
Healthcare ETF flows are reversing, offering a new tailwind for a sector that has underperformed for three years.
Cramer recommends buying Lockheed Martin and Ameriprise Financial shares.
Amazon Pharmacy's new program offers affordable access to weight-loss drugs for Medicare beneficiaries, potentially attracting more customers and establishing a relationship with patients.
President Trump's decision to end Medicare subsidies will raise prescription drug costs for 1.3 million New Yorkers.
The Dow Jones index surged to a fresh record high on Wednesday, driven by strong earnings reports, but the mixed performance of U.S. stocks and the weak job growth in July suggest that the market is still volatile.
The S&P 500's record close on Tuesday reflects the market's confidence in corporate America's strength, driven by strong earnings and easing geopolitical tensions.
The Dow Jones' record high and the Fear and Greed index's shift into the 'Greed' zone indicate a significant improvement in investor sentiment.
Company reports
No filings here yet
Official report cards for LLY will show up here when available.
Broad market indexes (like the S&P 500, a basket of 500 large US companies) are shown through popular funds that track them (for example SPY). Company profile and prices use live market data when available.